As the COVID-19 pandemic surged and made its impact felt, digital has transformed the manner in which society and industries approach the everyday. The digital transformation plans of many an organization accelerated as they sought to pivot to the demands of a brave new reality. Change that might have taken years instead came to fruition in months or even weeks, as radical changes in how companies conduct operations took root. But while change might be inevitable, it almost always raises question marks, and there are those that still linger for many industry participants as they remain unsure of what lies in the offing.
As a slew of innovations swept across the pharma landscape – right across intelligent machinery, advanced analytics, new treatment modalities, and much more – it has become increasingly imperative for organizations to embrace a holistic approach to building culture and capabilities enabled by the technologies that underpin them. Modern-day business leaders understand that optimal quality outcomes are tied to culture and capabilities, but creating a structure that sustains this can be challenging.
The solution lies in creating a “smart quality” framework, which would allow pharma companies to seize the initiative, helping them redesign key quality processes and create value for the organization by digitizing, automating, and integrating their quality controls, thereby optimising them for speed, effectiveness, and efficacy.
Forward-looking companies have begun to do exactly this by firming up plans to implement an array of new technologies that characterize Industry 4.0—from connectivity to advanced analytics, robotics, and automation— over the next decade. This smart quality approach will empower pharma companies, helping them embed quality controls into critical functions such as development and manufacturing.
To better understand the implications and integration of these broad-ranging technologies, the Pharma CXO Roundtable brings together a cross-section of pharma leaders and C-suite influencers. These industry doyens will jointly deliberate about the skills, mindsets, and pathways needed to drive true digital transformation, and shed light on the latest developments and way forward for the industry.
This high-powered roundtable will focus on helping participants gain a fuller understanding of a few critical areas, such as:
Deputy General Manager
Quality Assurance, Granules
Head Of Quality Assurance
Centaur Pharmaceuticals Pvt. Ltd.
Welcome address by Bluetech Media
Keynote address :
Join us in this informative session to understand how this reality is being realized across the industry spectrum.
Reimagining quality through the lens of a smart approach
Smart quality represents a paradigm shift that recognizes quality compliance as an enabler of enterprise value creation. This framework, which encompasses advanced technologies, modern process design techniques, and flexible ways of working, reimagines the approach taken to ensure quality, at a fraction of what it has historically cost, even as recently as 5 years ago.
Decoding Digital Transformation: What will the Pharma Landscape of Tomorrow Resemble ?
Closing address by Bluetech Media
Cocktail & Dinner
Express Pharma, today India’s leading business fortnightly for the pharmaceutical industry
Pharma Utility, a magazine dedicated to news and services in the Indian pharmaceutical industry.
India's most comprehensive online pharma news service. It provides updates on Indian pharma industry
IJDRA is Quarterly Open-access and peer-reviewed Journal circulated electronically and Print since 2013 .
Delegate Registration fee 3500 + GST
Copyright @ 2020 bluetech-media.com, All Rights Reserved,
Design & Develope by webtech.ooo